U.S. Retail REITs Stock News

Vishay Intertechnology (NYSE:VSH) has introduced the VCNL36758, a high sensitivity proximity sensor targeting smart home, industrial, and office uses. The device integrates an IR emitter, photodiode, amplifier, and ADC in a compact package to support presence detection, automation, and energy management applications. The launch highlights a new product focused on saving board space while broadening detection capabilities for next generation electronics. For investors tracking NYSE:VSH, this...

Intapp (INTA) shares are in focus after the company reported fiscal third quarter 2026 results, raised its full year outlook, and highlighted growth in SaaS and cloud annual recurring revenue alongside the launch of its Celeste AI platform. See our latest analysis for Intapp. At a share price of $23.98, Intapp has seen a 3.94% 1 day share price return and 6.82% 7 day share price return. The year to date share price return of 45.34% and 1 year total shareholder return of 56% show that momentum...

Leidos Holdings (LDOS) is back in focus after Q1 2026 results topped earnings and revenue estimates, management raised full year guidance, and the company closed its Entrust acquisition alongside several large US government contract wins. See our latest analysis for Leidos Holdings. Despite the stronger outlook and recent contract wins, the stock’s recent share price return has been weak, with a 30 day share price return showing a 17.38% decline and a year to date share price return showing a...

In early May 2026, BellRing Brands reported second-quarter fiscal 2026 results showing modest year-on-year sales growth to US$598.7 million but a sharp drop in net income to US$33.9 million and materially lower earnings per share, while also cutting full-year net sales guidance to flat–2% growth at US$2.33–US$2.37 billion. The results highlighted how heavier promotions, higher freight and protein costs, and an US$11 million inventory-related charge have compressed margins even as volumes...

Curtiss-Wright (CW) opened 2026 with Q1 revenue of US$913.7 million and Basic EPS of US$3.47, while trailing twelve month revenue sat at about US$3.6 billion with EPS of US$13.73 and net income of US$511.1 million. Over the last five reported quarters, revenue has moved from US$805.6 million in Q1 2025 to US$913.7 million in Q1 2026, with Basic EPS over that span ranging between US$2.69 and US$3.71. With trailing net profit margin edging higher over the past year, these results give investors...

Primerica (PRI) opened 2026 with Q1 revenue of US$885.9 million and basic EPS of US$6.00, supported by net income of US$190.1 million and a combined ratio of 65.2%, setting a clear tone for how the year is starting. The company has seen quarterly revenue move from US$803.4 million in Q4 2024 to US$819.5 million in Q1 2025 and then to US$885.9 million in Q1 2026. Over that period, basic EPS ranged from US$4.99 to US$6.36, pointing to a business that is still generating meaningful profits as...

Century Aluminum (CENX) has released its first quarter 2026 earnings, reporting revenue of US$649.2 million and net income of US$337.5 million, figures that sharply contrast with the prior year’s results. See our latest analysis for Century Aluminum. The stock has been active around the earnings release, with a 1-day share price return of a 3.26% decline, a 90-day share price return of 15.61% and a very large 1-year total shareholder return, suggesting momentum has been building over a longer...

In the first quarter of 2026, Clear Secure, Inc. reported revenue of US$253 million and net income of US$38.8 million, and also affirmed a quarterly dividend of US$0.15 per share payable on June 24, 2026. The company paired these record results with second-quarter 2026 revenue guidance of US$268 million–US$271 million and higher free cash flow expectations, highlighting growing traction for products like eGates and Concierge as it targets wider identity and GovTech opportunities. We’ll now...

If you are wondering whether Franklin Resources stock still offers value at current levels, it helps to start with how the market has been treating it recently and what that might imply about expectations. The stock last closed at US$30.52, with returns of 1.8% over 7 days, 28.3% over 30 days, 28.2% year to date, and 54.8% over 1 year. This puts recent price action firmly on investors' radar. Recent news coverage has focused on Franklin Resources' position as a global asset manager and its...

Why Huntsman Stock Is Back In Focus After Recent Company Updates Huntsman (HUN) has drawn fresh attention after management highlighted recent price increases, efforts to offset higher costs, and comments on demand trends and margins heading into the second quarter. See our latest analysis for Huntsman. Recent company updates on pricing, demand and margins have come alongside a 44.65% year to date share price return, while the 1 year total shareholder return of 30.18% contrasts with a weaker 3...

ResMed (RMD) recently combined a CFO transition with quarterly results that showed higher sales, net income and earnings per share year over year, a mix that tends to sharpen investor focus on the stock. See our latest analysis for ResMed. Even with higher quarterly sales and earnings, ResMed’s recent share price has been under pressure, with a 30 day share price return of an 8.48% decline and a 90 day share price return of a 23.83% decline. The 1 year total shareholder return of a 14.31%...

In the past quarter, NOV Inc. repurchased 3,500,000 shares for US$67 million, completing a broader buyback of 40,475,436 shares for US$611.23 million under its April 26, 2024 authorization, while reporting first-quarter 2026 revenue of US$2,052 million and net income of US$19 million, both lower than a year earlier. The earnings release, guidance for a 4% to 6% year-over-year revenue decline in the second quarter of 2026, and Barclays’ downgrade to Underweight despite a more positive view on...

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...

Chubb (NYSE:CB) has formed an alliance with Verified Clinical Trials to support risk management and data quality in clinical research. The partnership focuses on research subject safety, data integrity, and reducing operational and regulatory risks using VCT's subject registry technology. This development extends Chubb's activity beyond traditional insurance coverage into technology driven clinical trial risk solutions. For investors tracking Chubb at a current share price of $321.28, the...

Why Biogen (BIIB) is on investors’ radar today Biogen (BIIB) has drawn fresh attention after recent share price moves, with the stock up about 9% over the past month but showing a roughly 5% decline over the past 3 months. See our latest analysis for Biogen. The recent 8.98% 1 month share price return, alongside a 7.63% year to date share price return and 61.65% 1 year total shareholder return, suggests momentum has picked up again after weaker 3 year and 5 year total shareholder returns. If...

Why Buckle Stock Is Back On Investors’ Radar Buckle (BKE) is attracting fresh attention after a period of mixed short term returns, with the stock showing a small gain over the past month and a modest rise over the past 3 months. See our latest analysis for Buckle. Short term share price momentum has cooled, with a 1 day share price return decline of 4.01% and a 7 day share price return decline of 5.84%, while the 1 year total shareholder return of 53.77% still points to a strong longer term...

If you are wondering whether Constellation Energy stock is trading at an attractive price or starting to look stretched, the key is understanding what the current valuation is really telling you. The stock last closed at US$311.28, with returns of 14.2% over the past 30 days and 15.6% over the last year, set against a 15.0% decline year to date and a very large gain over three years. Recent headlines around Constellation Energy have focused on its position within the utilities sector and...

In early May 2026, TowneBank was caught up in a broader regional bank pullback as renewed U.S.-Iran tensions drove oil prices higher and pushed Treasury yields toward nine-month highs, rekindling stagflation worries. This episode highlights how quickly the macro backdrop, especially inflation-driven moves in the yield curve, can alter perceptions of earnings resilience for regional lenders like TowneBank. We’ll now examine how this inflation-driven shift in Treasury yields may influence...

If you are wondering whether Entergy stock still offers value at recent prices, it helps to step back and look at both the recent returns and what they might be pricing in. The stock last closed at US$112.02, with a 7 day return of a 5% decline, a 30 day return of a 1.6% decline, and a gain of 19.3% year to date and 37.9% over the past year, with multi year returns that have been very large over 3 and 5 years. Recent price moves sit against a backdrop of ongoing interest in regulated...

Why Independent Bank's new buyback is drawing attention Independent Bank (INDB) has put a fresh US$200 million share repurchase program on the table, running through April 2027, which immediately puts capital returns and valuation front and center for investors. See our latest analysis for Independent Bank. Independent Bank's share price has softened recently, with a 9.05% 90 day share price return, yet the 1 year total shareholder return of 30.63% and 3 year total shareholder return of...

In the first quarter of 2026, Zevra Therapeutics reported sales of US$36.22 million, net income of US$37.89 million, and a swing to positive earnings per share, supported by a US$43.3 million gain from selling its SDX portfolio and retiring US$63.1 million of term debt. At the same time, Zevra sharpened its rare disease focus with early MyPlifer traction in Niemann-Pick disease type C, progress on celiprolol for vascular Ehlers-Danlos syndrome, and a strong cash position of US$236.8 million,...

Wondering if Shopify at around US$111.74 fairly reflects its potential, or if the stock price is getting ahead of itself. Shopify's share price has returned 18.9% over the last year, but is down 7.8% over the past week, 4.5% over the past month, and 28.9% year to date, which may have shifted how investors view its risk and opportunity. Recent coverage has focused on how Shopify fits into longer term themes in e-commerce and software, as well as how investors are reassessing growth oriented...

Wondering if Intellia Therapeutics at around US$13.71 is offering value or just volatility? This article walks through what the current price may be implying about the stock. The stock has returned 1.7% over the last 7 days, 1.2% over 30 days, 48.9% year to date and 65.6% over the past year, while longer term 3 year and 5 year returns of 69.3% and 77.5% declines show how sentiment around the stock has shifted over time. Recent headlines around Intellia Therapeutics have focused on its...

In early May 2026, AdaptHealth Corp. reported first-quarter net revenue of US$819.8 million, a wider net loss of US$16.04 million, completed a US$1.10 billion refinancing of its senior secured credit facility, and raised its 2026 net revenue guidance to US$3.45 billion–US$3.52 billion. Management highlighted that the stronger balance sheet will support disciplined tuck-in acquisitions in core Sleep and Respiratory Health, alongside a large de novo expansion and an advanced digital patient...